KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) EPS (Weighted Average and Diluted) (2019 - 2025)

Guardant Health's EPS (Weighted Average and Diluted) history spans 7 years, with the latest figure at -$1.01 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 12.22% year-over-year to -$1.01; the TTM value through Dec 2025 reached -$3.32, up 6.74%, while the annual FY2025 figure was -$3.32, 6.74% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$1.01 at Guardant Health, down from -$0.74 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at -$0.65 in Q2 2023 and bottomed at -$2.25 in Q2 2022.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.95 (2021), against an average of -$1.08.
  • The largest annual shift saw EPS (Weighted Average and Diluted) crashed 134.38% in 2022 before it skyrocketed 71.11% in 2023.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.89 in 2021, then crashed by 53.93% to -$1.37 in 2022, then fell by 18.25% to -$1.62 in 2023, then surged by 44.44% to -$0.9 in 2024, then decreased by 12.22% to -$1.01 in 2025.
  • Per Business Quant, the three most recent readings for GH's EPS (Weighted Average and Diluted) are -$1.01 (Q4 2025), -$0.74 (Q3 2025), and -$0.8 (Q2 2025).